Firstpost
  • Home
  • Video Shows
    Vantage Firstpost America Firstpost Africa First Sports
  • World
    US News
  • Explainers
  • News
    India Opinion Cricket Tech Entertainment Sports Health Photostories
  • Asia Cup 2025
Apple Incorporated Modi ji Justin Trudeau Trending

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit
Trending:
  • Nepal protests
  • Nepal Protests Live
  • Vice-presidential elections
  • iPhone 17
  • IND vs PAK cricket
  • Israel-Hamas war
fp-logo
Strides Arcolab to buy Aspen's generics biz for Rs 1910 cr, shares rise 9%
Whatsapp Facebook Twitter
Whatsapp Facebook Twitter
Apple Incorporated Modi ji Justin Trudeau Trending

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit
  • Home
  • Business
  • Strides Arcolab to buy Aspen's generics biz for Rs 1910 cr, shares rise 9%

Strides Arcolab to buy Aspen's generics biz for Rs 1910 cr, shares rise 9%

FP Archives • May 22, 2015, 07:53:23 IST
Whatsapp Facebook Twitter

The transaction will be financed by a combination of internal accruals and debt financing

Advertisement
Subscribe Join Us
Add as a preferred source on Google
Prefer
Firstpost
On
Google
Strides Arcolab to buy Aspen's generics biz for Rs 1910 cr, shares rise 9%

Strides Arcolab today said it will acquire South Africa’s Aspen Pharmacare’s portfolio of branded and generics products in Australia for about Rs 1,910 crore. Shares of Strides Arcolab surged as much as 9.30 per cent in intraday trade on Thursday. The stock ended in green, up 8.56 per cent or Rs 93.70 at Rs 1,187.9. The company’s market value rose by Rs. 558.74 crore to Rs. 7,081.74 crore. [caption id=“attachment_1499919” align=“alignleft” width=“380”] ![Representational image. AFP](https://images.firstpost.com/wp-content/uploads/2014/04/PharmaDrugsRepresentational.jpg) Representational image. AFP[/caption] The deal will facilitate re-entry of Strides in the Australian market. In a BSE filing Strides Arcolab said: “Strides Pharma Global Pte. Ltd and Strides (Australia) Pharma Pty Ltd, Australia, both wholly-owned subsidiaries of Strides Arcolab have signed definitive agreement with certain wholly subsidiaries of Aspen Pharmacare to acquire a generic pharmaceutical business in Australia with certain branded pharmaceutical assets.” It further said: “The consideration for the acquisition will be approximately Australian Dollar 380 million. The acquisition…include access to the product pipeline that was under development by Aspen and includes a number of major product launches in the next six months.” Strides Arcolab Founder and Group CEO Arun Kumar said: “Aspen’s Australian generic pharmaceutical assets are a valuable and unique platform for Strides to rebuild its business in Australia.” The portfolio of Aspen’s 130 products in Australia comprises generic pharmaceutical business together with certain branded pharmaceutical assets. Australia’s pharmaceutical market is expected to grow to $32.1 billion by 2020 from $22.7 billion in 2013, according to market research firm Global Data, driven by rising health insurance cover and an increasing elderly population. The deal also covers the sale by Aspen’s Mauritius unit of a portfolio of six branded prescription drugs to Strides’ Singapore business. The company said that the acquired products has sales of Australian Dollar 120 million in the fiscal year ended June 2014. The Australian business will operate under the Arrrow Pharmaceuticals brand and will sell both prescription and non-prescription products, it said. The transaction will be financed by a combination of internal accruals and debt financing. The transaction is expected to close by end of second quarter of 2015-16. The moves are the latest in a series by Strides to streamline its portfolio of assets. It bought Chennai, India-based drug ingredients maker Shasun Pharmaceuticals Ltd for $200 million last September, while in 2013 it sold its injectable drugs unit, Agila Specialties, to US firm Mylan NV for about $1.6 billion. This is the second time Strides is trying its luck in the Australian market. In 2012, Strides Arcolab exited the market by selling its entire stake in Ascent Pharmahealth, its subsidiary in that country, to Watson Pharmaceuticals for 375 million Australian dollars. Agencies

Tags
DealStream Strides Arcolab
End of Article
Written by FP Archives

see more

Latest News
Find us on YouTube
Subscribe
End of Article

Impact Shorts

Tata Harrier EV vs Mahindra XEV 9e: Design and road presence compared

Tata Harrier EV vs Mahindra XEV 9e: Design and road presence compared

The Tata Harrier EV and Mahindra XEV 9e are new electric SUVs in India. The Harrier EV has a modern, familiar design, while the XEV 9e features a bold, striking look. They cater to different preferences: the Harrier EV for subtle elegance and the XEV 9e for expressive ruggedness.

More Impact Shorts

Top Stories

Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty

Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty

Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched

Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched

Who is CP Radhakrishnan, India's next vice-president?

Who is CP Radhakrishnan, India's next vice-president?

Israel informed US ahead of strikes on Hamas leaders in Doha, says White House

Israel informed US ahead of strikes on Hamas leaders in Doha, says White House

Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty

Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty

Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched

Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched

Who is CP Radhakrishnan, India's next vice-president?

Who is CP Radhakrishnan, India's next vice-president?

Israel informed US ahead of strikes on Hamas leaders in Doha, says White House

Israel informed US ahead of strikes on Hamas leaders in Doha, says White House

Top Shows

Vantage Firstpost America Firstpost Africa First Sports
Latest News About Firstpost
Most Searched Categories
  • Web Stories
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Tech/Auto
  • Entertainment
  • IPL 2025
NETWORK18 SITES
  • News18
  • Money Control
  • CNBC TV18
  • Forbes India
  • Advertise with us
  • Sitemap
Firstpost Logo

is on YouTube

Subscribe Now

Copyright @ 2024. Firstpost - All Rights Reserved

About Us Contact Us Privacy Policy Cookie Policy Terms Of Use
Home Video Shorts Live TV